Obesity-news.com THE LATEST IN OBESITY RESEARCH AND WEIGHTLOSS DRUG DEVELOPMENT     Join our list More information      Sample issues Full-text sample issues and articles are maintained on the site for prospective subscribers. There are a full-text sample copies of Obesity-update and and Obesity-news on-line. Articles are removed from the public pages approximately one year after publication. All back issues are retained in the subscriber database. On-line sample newsletters August 2000 Obesity-news. January 2005 Obesity-update. Sample articles Most recent additions Calcium and weight loss. Obesity 101, June 2000. Sample drugs in development report. October 2002 (updated from October 1998). Other publicly available articles A hormone that causes fat loss. April/May 2001. Acipimox and insulin resistance. November 2000. Aminosterol and weight loss. August 2000. Amylin. May 2000. Amylin and gastric emptying. May 2000. CCK, hunger and energy consumption. November 2000. Chitosan and fat absorption. November 2000. Corticotropin releasing hormone and energy expenditure. November 2000. Could the obesity epidemic be caused by a virus? August 2000. Dietary fat and leptin resistance. March 2001, subscribers. Dietary fat and the weight reduced woman. April/May 2001, subscribers. Do you know why you get the munchies? July 2000. Dopamine and obesity. February 2001. Dopamine, leptin and hyperphagia. July 2000. Drug development update. August 2000. Gender differences in weight maintenance. March 2000. Gene that regulates fat production found. May 2000. Human growth hormone fragment update. Dec 2000/Jan 2001. Melatonin and body weight. February/March 2000. Melanocortin and obesity. September 2000. More on diet and weight gain. March 2000. More on fat and leptin. March 2001. More on the European Union phentermine ban. August 2000. More on the phentermine shortage. August 2000. More on vagal nerve stimulation and obesity. August 2000. New lipase inhibitor completes phase 1 trial. August 2000. Obesity, aging and leptin resistance. February 2001. Other news. Dec 2000/Jan 2001. Phenylpropanolamine withdrawal. Dec 2000/Jan 2001. Phosphatase inhibitors and type-2 diabetes. May 2000. Roche files new drug application for Xenical. June 2001. Sibutramine and hypertension. August 2000. Successful long term weight maintenance. September 2000. UCP-3 and thermogenesis in humans. August 2000. Zinc. May 2000. Zinc and glucose sensitivity. May 2000. Zinc deficiency and food intake. May 2000. Zinc deficiency and thyroid hormone. May 2000. Other sample articles are available in the Obesity-101 archives. Home|Subscribe|Archives|Drug info|Contact|Media & Links|Site index|FAQs|Doctors/meetings|Admin Obesity-news is a publication of Hirsch Communications. An on-line subscription is $104.00 per year, payable in advance by check, money order, American Express, Discover, VISA or Mastercard. Subscribing is simple using our secure on-line subscription form. Obesity-news also accepts fax orders at 703/960-7462 and mail orders at PO Box 19316, Alexandria, VA 22320-0316. Copyright 1997-2008, all rights reserved. IMPORTANT: All information in this publication is believed to be accurate and true. Publisher is not liable for omissions or inaccuracies. Information in this newsletter is for educational purposes only and should not be construed as medical advice, or be used in lieu of consultation with a health care provider.